美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

SAB Biotherapeutics, Inc. Warrant

0.0281

-0.0001-0.35%

成交量：902.00

成交额：24.54

市值：- -

市盈率：- -

高：0.0281

开：0.0281

低：0.0265

收：0.0282

52周最高：0.1800

52周最低：0.0179

股本：- -

流通股本：- -

量比：0.08

换手率：- -

股息：- -

股息率：- -

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻公告

Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)盘中异动早盘快速跳水7.33%报0.028美元

Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)股价飙升12.55% 市值涨11.22万美元

Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)盘中异动急速拉升6.76%

Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)盘中异动临近午盘大幅下挫6.13%

Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)股价拉升20.71% 市值涨21.81万美元

Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)股价飙升49.09% 市值涨62.69万美元

Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)股价重挫14.04% 市值跌13.11万美元

Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)盘中异动早盘股价大跌16.00%

Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)盘中异动早盘急速跳水24.57%

Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)盘中异动大幅下挫20.25%

Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)股价上涨75.44% 市值涨235万美元

Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)盘中异动股价大涨9.62%报0.057美元

Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)盘中异动急速下挫12.13%报0.050美元

Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)盘中异动早盘股价大涨5.88%

Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)盘中异动快速下挫10.01%

Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)盘中异动大幅下挫30.00%

Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)盘中异动快速拉升20.12%

Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)盘中异动大幅拉升13.65%

Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)盘中异动股价大涨8.66%

Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)股价重挫13.70% 市值跌10.75万美元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/SABSW/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SABSW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SABSW\",,,,,undefined,":{"symbol":"SABSW","market":"US","secType":"STK","nameCN":"SAB Biotherapeutics, Inc. Warrant","latestPrice":0.0281,"timestamp":1755288000000,"preClose":0.0282,"halted":0,"volume":902,"delay":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":-0.0001,"latestTime":"08-15 16:00:00 EDT","open":0.0281,"high":0.0281,"low":0.0265,"amount":24.5424,"amplitude":0.056738,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1755504000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.0282,"preHourTrading":{"tag":"盘前","latestPrice":0.0262,"preClose":0.0278,"latestTime":"08:56 EDT","volume":2,"amount":0.0524,"timestamp":1755262613995},"volumeRatio":0.08313364001664933},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SABSW\",,,,,undefined,":{"symbol":"SABSW","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.08313364001664933,"shares":0,"dividePrice":0,"high":0.0281,"amplitude":0.056738,"preClose":0.0282,"low":0.0265,"week52Low":0.0179,"pbRate":"--","week52High":0.18,"institutionHeld":0,"latestPrice":0.0281,"eps":0,"divideRate":0,"volume":902,"delay":0,"ttmEps":0,"open":0.0281,"prevYearClose":0.0753,"prevWeekClose":0.0278,"prevMonthClose":0.031,"prevQuarterClose":0.0333,"fiveDayClose":0.0278,"twentyDayClose":0.057,"sixtyDayClose":0.0221},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SABSW\",params:#limit:5,,,undefined,":[{"market":"US","date":"2022-08-10","symbol":"SABSW","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘前","type":"earning","dateTimestamp":1660104000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2022-03-29","symbol":"SABSW","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1648526400000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SABSW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SABSW\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SABSW\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2557520440","title":"Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)盘中异动 早盘快速跳水7.33%报0.028美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557520440","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557520440?lang=zh_cn&edition=fundamental","pubTime":"2025-08-08 22:01","pubTimestamp":1754661662,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日22时01分，Sab Biotherapeutics Inc C/Wts 22/10/2026 股票出现波动，股价大幅下挫7.33%。Sab Biotherapeutics Inc C/Wts 22/10/2026 股票所在的生物技术行业中，整体跌幅为0.28%。Sab Biotherapeutics Inc C/Wts 22/10/2026 公司简介：SAB Biotherapeutics Inc 是一家临床阶段的生物制药公司，专注于开发和商业化其专有免疫治疗平台的产品组合，以生产完全靶向的人多克隆抗体，而无需使用人血浆或血清。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808220102a47d66e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808220102a47d66e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SABSW"],"gpt_icon":0},{"id":"2557019493","title":"Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)股价飙升12.55% 市值涨11.22万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557019493","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557019493?lang=zh_cn&edition=fundamental","pubTime":"2025-08-07 02:40","pubTimestamp":1754505601,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日02时40分，Sab Biotherapeutics Inc C/Wts 22/10/2026 股票出现异动，股价大幅拉升12.55%。Sab Biotherapeutics Inc C/Wts 22/10/2026 股票所在的生物技术行业中，整体跌幅为0.19%。Sab Biotherapeutics Inc C/Wts 22/10/2026 公司简介：SAB Biotherapeutics Inc 是一家临床阶段的生物制药公司，专注于开发和商业化其专有免疫治疗平台的产品组合，以生产完全靶向的人多克隆抗体，而无需使用人血浆或血清。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807024001a6d712db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807024001a6d712db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SABSW"],"gpt_icon":0},{"id":"2557333399","title":"Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)盘中异动 急速拉升6.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557333399","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557333399?lang=zh_cn&edition=fundamental","pubTime":"2025-08-05 00:19","pubTimestamp":1754324340,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日00时19分，Sab Biotherapeutics Inc C/Wts 22/10/2026 股票出现异动，股价快速上涨6.76%。Sab Biotherapeutics Inc C/Wts 22/10/2026 股票所在的生物技术行业中，整体涨幅为1.15%。Sab Biotherapeutics Inc C/Wts 22/10/2026 公司简介：SAB Biotherapeutics Inc 是一家临床阶段的生物制药公司，专注于开发和商业化其专有免疫治疗平台的产品组合，以生产完全靶向的人多克隆抗体，而无需使用人血浆或血清。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805001900a474cbdc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805001900a474cbdc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SABSW"],"gpt_icon":0},{"id":"2556357810","title":"Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)盘中异动 临近午盘大幅下挫6.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556357810","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556357810?lang=zh_cn&edition=fundamental","pubTime":"2025-08-02 00:14","pubTimestamp":1754064841,"startTime":"0","endTime":"0","summary":"北京时间2025年08月02日00时14分，Sab Biotherapeutics Inc C/Wts 22/10/2026 股票出现波动，股价大幅下挫6.13%。Sab Biotherapeutics Inc C/Wts 22/10/2026 股票所在的生物技术行业中，整体涨幅为0.32%。Sab Biotherapeutics Inc C/Wts 22/10/2026 公司简介：SAB Biotherapeutics Inc 是一家临床阶段的生物制药公司，专注于开发和商业化其专有免疫治疗平台的产品组合，以生产完全靶向的人多克隆抗体，而无需使用人血浆或血清。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802001401a470196c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802001401a470196c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SABSW"],"gpt_icon":0},{"id":"2555025635","title":"Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)股价拉升20.71% 市值涨21.81万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555025635","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555025635?lang=zh_cn&edition=fundamental","pubTime":"2025-07-31 00:26","pubTimestamp":1753892761,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日00时26分，Sab Biotherapeutics Inc C/Wts 22/10/2026 股票出现波动，股价大幅拉升20.71%。Sab Biotherapeutics Inc C/Wts 22/10/2026 股票所在的生物技术行业中，整体涨幅为0.66%。Sab Biotherapeutics Inc C/Wts 22/10/2026 公司简介：SAB Biotherapeutics Inc 是一家临床阶段的生物制药公司，专注于开发和商业化其专有免疫治疗平台的产品组合，以生产完全靶向的人多克隆抗体，而无需使用人血浆或血清。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731002601a46be98f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731002601a46be98f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SABSW"],"gpt_icon":0},{"id":"2555709808","title":"Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)股价飙升49.09% 市值涨62.69万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555709808","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555709808?lang=zh_cn&edition=fundamental","pubTime":"2025-07-29 03:45","pubTimestamp":1753731901,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日03时45分，Sab Biotherapeutics Inc C/Wts 22/10/2026 股票出现波动，股价大幅拉升49.09%。Sab Biotherapeutics Inc C/Wts 22/10/2026 股票所在的生物技术行业中，整体跌幅为0.57%。Sab Biotherapeutics Inc C/Wts 22/10/2026 公司简介：SAB Biotherapeutics Inc 是一家临床阶段的生物制药公司，专注于开发和商业化其专有免疫治疗平台的产品组合，以生产完全靶向的人多克隆抗体，而无需使用人血浆或血清。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729034501a6c66983&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729034501a6c66983&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SABSW"],"gpt_icon":0},{"id":"2554817794","title":"Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)股价重挫14.04% 市值跌13.11万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554817794","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554817794?lang=zh_cn&edition=fundamental","pubTime":"2025-07-26 03:27","pubTimestamp":1753471621,"startTime":"0","endTime":"0","summary":"北京时间2025年07月26日03时27分，Sab Biotherapeutics Inc C/Wts 22/10/2026 股票出现异动，股价快速跳水14.04%。Sab Biotherapeutics Inc C/Wts 22/10/2026 股票所在的生物技术行业中，整体涨幅为0.24%。Sab Biotherapeutics Inc C/Wts 22/10/2026 公司简介：SAB Biotherapeutics Inc 是一家临床阶段的生物制药公司，专注于开发和商业化其专有免疫治疗平台的产品组合，以生产完全靶向的人多克隆抗体，而无需使用人血浆或血清。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726032701a6c2233e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726032701a6c2233e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SABSW"],"gpt_icon":0},{"id":"2553428789","title":"Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)盘中异动 早盘股价大跌16.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553428789","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553428789?lang=zh_cn&edition=fundamental","pubTime":"2025-07-24 22:46","pubTimestamp":1753368360,"startTime":"0","endTime":"0","summary":"北京时间2025年07月24日22时46分，Sab Biotherapeutics Inc C/Wts 22/10/2026 股票出现波动，股价大幅跳水16.00%。Sab Biotherapeutics Inc C/Wts 22/10/2026 股票所在的生物技术行业中，整体涨幅为0.41%。Sab Biotherapeutics Inc C/Wts 22/10/2026 公司简介：SAB Biotherapeutics Inc 是一家临床阶段的生物制药公司，专注于开发和商业化其专有免疫治疗平台的产品组合，以生产完全靶向的人多克隆抗体，而无需使用人血浆或血清。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724224600a4618b46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724224600a4618b46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SABSW"],"gpt_icon":0},{"id":"2553246559","title":"Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)盘中异动 早盘急速跳水24.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553246559","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553246559?lang=zh_cn&edition=fundamental","pubTime":"2025-07-23 21:51","pubTimestamp":1753278670,"startTime":"0","endTime":"0","summary":"北京时间2025年07月23日21时51分，Sab Biotherapeutics Inc C/Wts 22/10/2026 股票出现波动，股价大幅下跌24.57%。Sab Biotherapeutics Inc C/Wts 22/10/2026 股票所在的生物技术行业中，整体涨幅为0.61%。Sab Biotherapeutics Inc C/Wts 22/10/2026 公司简介：SAB Biotherapeutics Inc 是一家临床阶段的生物制药公司，专注于开发和商业化其专有免疫治疗平台的产品组合，以生产完全靶向的人多克隆抗体，而无需使用人血浆或血清。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507232151109719f985&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507232151109719f985&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SABSW"],"gpt_icon":0},{"id":"2553259440","title":"Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)盘中异动 大幅下挫20.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553259440","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553259440?lang=zh_cn&edition=fundamental","pubTime":"2025-07-22 21:33","pubTimestamp":1753191194,"startTime":"0","endTime":"0","summary":"北京时间2025年07月22日21时33分，Sab Biotherapeutics Inc C/Wts 22/10/2026 股票出现异动，股价快速下挫20.25%。Sab Biotherapeutics Inc C/Wts 22/10/2026 股票所在的生物技术行业中，整体涨幅为0.37%。Sab Biotherapeutics Inc C/Wts 22/10/2026 公司简介：SAB Biotherapeutics Inc 是一家临床阶段的生物制药公司，专注于开发和商业化其专有免疫治疗平台的产品组合，以生产完全靶向的人多克隆抗体，而无需使用人血浆或血清。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722213314a6bb0952&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722213314a6bb0952&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SABSW"],"gpt_icon":0},{"id":"2553472770","title":"Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)股价上涨75.44% 市值涨235万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553472770","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553472770?lang=zh_cn&edition=fundamental","pubTime":"2025-07-21 21:31","pubTimestamp":1753104668,"startTime":"0","endTime":"0","summary":"北京时间2025年07月21日21时31分，Sab Biotherapeutics Inc C/Wts 22/10/2026 股票出现异动，股价大幅拉升75.44%。Sab Biotherapeutics Inc C/Wts 22/10/2026 股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Promis Neurosciences Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Sab Biotherapeutics, Inc.涨幅较大，Tnf Pharmaceuticals, Inc.、Promis Neurosciences Inc.、Sab Biotherapeutics, Inc.较为活跃，换手率分别为1338.47%、339.45%、210.07%，振幅较大的相关个股有Promis Neurosciences Inc.、Cyclacel Pharmaceuticals, Inc.、康乃德生物，振幅分别为24.99%、11.55%、8.45%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721213108a459b134&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721213108a459b134&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SABSW"],"gpt_icon":0},{"id":"2552314438","title":"Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)盘中异动 股价大涨9.62%报0.057美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552314438","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552314438?lang=zh_cn&edition=fundamental","pubTime":"2025-07-17 23:46","pubTimestamp":1752767161,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日23时46分，Sab Biotherapeutics Inc C/Wts 22/10/2026 股票出现波动，股价急速上涨9.62%。Sab Biotherapeutics Inc C/Wts 22/10/2026 股票所在的生物技术行业中，整体涨幅为0.11%。Sab Biotherapeutics Inc C/Wts 22/10/2026 公司简介：SAB Biotherapeutics Inc 是一家临床阶段的生物制药公司，专注于开发和商业化其专有免疫治疗平台的产品组合，以生产完全靶向的人多克隆抗体，而无需使用人血浆或血清。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717234601a451777c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717234601a451777c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SABSW"],"gpt_icon":0},{"id":"2551257821","title":"Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)盘中异动 急速下挫12.13%报0.050美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551257821","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551257821?lang=zh_cn&edition=fundamental","pubTime":"2025-07-16 21:31","pubTimestamp":1752672718,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日21时31分，Sab Biotherapeutics Inc C/Wts 22/10/2026 股票出现异动，股价急速下跌12.13%。Sab Biotherapeutics Inc C/Wts 22/10/2026 股票所在的生物技术行业中，整体涨幅为0.40%。Sab Biotherapeutics Inc C/Wts 22/10/2026 公司简介：SAB Biotherapeutics Inc 是一家临床阶段的生物制药公司，专注于开发和商业化其专有免疫治疗平台的产品组合，以生产完全靶向的人多克隆抗体，而无需使用人血浆或血清。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716213158a44edf55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716213158a44edf55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SABSW"],"gpt_icon":0},{"id":"2551874771","title":"Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)盘中异动 早盘股价大涨5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551874771","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551874771?lang=zh_cn&edition=fundamental","pubTime":"2025-07-14 21:33","pubTimestamp":1752499986,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日21时33分，Sab Biotherapeutics Inc C/Wts 22/10/2026 股票出现波动，股价大幅拉升5.88%。Sab Biotherapeutics Inc C/Wts 22/10/2026 股票所在的生物技术行业中，整体跌幅为0.11%。Sab Biotherapeutics Inc C/Wts 22/10/2026 公司简介：SAB Biotherapeutics Inc 是一家临床阶段的生物制药公司，专注于开发和商业化其专有免疫治疗平台的产品组合，以生产完全靶向的人多克隆抗体，而无需使用人血浆或血清。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714213306a6a8f0bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714213306a6a8f0bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SABSW"],"gpt_icon":0},{"id":"2550625628","title":"Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)盘中异动 快速下挫10.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550625628","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550625628?lang=zh_cn&edition=fundamental","pubTime":"2025-07-10 21:31","pubTimestamp":1752154310,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日21时31分，Sab Biotherapeutics Inc C/Wts 22/10/2026 股票出现波动，股价快速下跌10.01%。Sab Biotherapeutics Inc C/Wts 22/10/2026 股票所在的生物技术行业中，整体跌幅为0.14%。Sab Biotherapeutics Inc C/Wts 22/10/2026 公司简介：SAB Biotherapeutics Inc 是一家临床阶段的生物制药公司，专注于开发和商业化其专有免疫治疗平台的产品组合，以生产完全靶向的人多克隆抗体，而无需使用人血浆或血清。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710213150a6a1c13c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710213150a6a1c13c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","SABSW","CGTX"],"gpt_icon":0},{"id":"2549525074","title":"Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)盘中异动 大幅下挫30.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549525074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549525074?lang=zh_cn&edition=fundamental","pubTime":"2025-07-08 22:51","pubTimestamp":1751986261,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日22时51分，Sab Biotherapeutics Inc C/Wts 22/10/2026 股票出现波动，股价急速下跌30.00%。Sab Biotherapeutics Inc C/Wts 22/10/2026 股票所在的生物技术行业中，整体涨幅为1.17%。Sab Biotherapeutics Inc C/Wts 22/10/2026 公司简介：SAB Biotherapeutics Inc 是一家临床阶段的生物制药公司，专注于开发和商业化其专有免疫治疗平台的产品组合，以生产完全靶向的人多克隆抗体，而无需使用人血浆或血清。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708225101a43e4ff6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708225101a43e4ff6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","SABSW","RLYB"],"gpt_icon":0},{"id":"2548581576","title":"Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)盘中异动 快速拉升20.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548581576","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548581576?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 22:26","pubTimestamp":1751466361,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日22时26分，Sab Biotherapeutics Inc C/Wts 22/10/2026 股票出现波动，股价快速上涨20.12%。Sab Biotherapeutics Inc C/Wts 22/10/2026 股票所在的生物技术行业中，整体涨幅为0.79%。Sab Biotherapeutics Inc C/Wts 22/10/2026 公司简介：SAB Biotherapeutics Inc 是一家临床阶段的生物制药公司，专注于开发和商业化其专有免疫治疗平台的产品组合，以生产完全靶向的人多克隆抗体，而无需使用人血浆或血清。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702222601a4cb6857&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702222601a4cb6857&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SABSW"],"gpt_icon":0},{"id":"2547097276","title":"Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)盘中异动 大幅拉升13.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2547097276","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547097276?lang=zh_cn&edition=fundamental","pubTime":"2025-06-30 21:32","pubTimestamp":1751290350,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日21时32分，Sab Biotherapeutics Inc C/Wts 22/10/2026 股票出现异动，股价快速拉升13.65%。Sab Biotherapeutics Inc C/Wts 22/10/2026 股票所在的生物技术行业中，整体涨幅为0.00%。Sab Biotherapeutics Inc C/Wts 22/10/2026 公司简介：SAB Biotherapeutics Inc 是一家临床阶段的生物制药公司，专注于开发和商业化其专有免疫治疗平台的产品组合，以生产完全靶向的人多克隆抗体，而无需使用人血浆或血清。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213231a4c6c4d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213231a4c6c4d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SABSW"],"gpt_icon":0},{"id":"2546753321","title":"Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)盘中异动 股价大涨8.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546753321","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546753321?lang=zh_cn&edition=fundamental","pubTime":"2025-06-27 01:27","pubTimestamp":1750958821,"startTime":"0","endTime":"0","summary":"北京时间2025年06月27日01时27分，Sab Biotherapeutics Inc C/Wts 22/10/2026 股票出现波动，股价急速拉升8.66%。Sab Biotherapeutics Inc C/Wts 22/10/2026 股票所在的生物技术行业中，整体跌幅为0.33%。Sab Biotherapeutics Inc C/Wts 22/10/2026 公司简介：SAB Biotherapeutics Inc 是一家临床阶段的生物制药公司，专注于开发和商业化其专有免疫治疗平台的产品组合，以生产完全靶向的人多克隆抗体，而无需使用人血浆或血清。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627012701a71f3f22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627012701a71f3f22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SABSW"],"gpt_icon":0},{"id":"2546317222","title":"Sab Biotherapeutics Inc C/Wts 22/10/2026 (To Pur Com)股价重挫13.70% 市值跌10.75万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546317222","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546317222?lang=zh_cn&edition=fundamental","pubTime":"2025-06-24 23:25","pubTimestamp":1750778701,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日23时25分，Sab Biotherapeutics Inc C/Wts 22/10/2026 股票出现异动，股价大幅跳水13.70%。Sab Biotherapeutics Inc C/Wts 22/10/2026 股票所在的生物技术行业中，整体涨幅为1.78%。Sab Biotherapeutics Inc C/Wts 22/10/2026 公司简介：SAB Biotherapeutics Inc 是一家临床阶段的生物制药公司，专注于开发和商业化其专有免疫治疗平台的产品组合，以生产完全靶向的人多克隆抗体，而无需使用人血浆或血清。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624232501a4bbbcb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624232501a4bbbcb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SABSW"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":54,"code":"91000000","status":"200"}]}}